Comparison of in vivo and in vitro drug sensitivities of Lewis lung carcinoma and P388 leukaemia to analogues of Amsacrine
- 30 June 1987
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer and Clinical Oncology
- Vol. 23 (6), 607-613
- https://doi.org/10.1016/0277-5379(87)90254-9
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The use of human cancer cell lines as a primary screening system for antineoplastic compoundsEuropean Journal of Cancer and Clinical Oncology, 1984
- Differential growth inhibition of cultured mammalian cells: Comparison of clinical antitumour agents and amsacrine derivativesEuropean Journal of Cancer and Clinical Oncology, 1984
- Potential antitumor agents. 40. Orally active 4,5-disubstituted derivatives of amsacrineJournal of Medicinal Chemistry, 1984
- Divergent activity of derivatives of amsacrine (m-AMSA) towards Lewis lung carcinoma and P388 leukaemia in miceEuropean Journal of Cancer and Clinical Oncology, 1983
- Potential antitumor agents. 36. Quantitative relationships between experimental antitumor activity, toxicity, and structure for the general class of 9-anilinoacridine antitumor agentsJournal of Medicinal Chemistry, 1982
- Antitumour activity of substituted 9-anilinoacridines—Comparison of in vivo and in vitro testing systemsEuropean Journal of Cancer (1965), 1981
- Current results of the screening program at the division of cancer treatment, national cancer instituteEuropean Journal of Cancer (1965), 1981
- Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemiaBiochemical Pharmacology, 1978
- In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stainExperimental Cell Research, 1977